Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
AIDS (London, England)
|
December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status
Sarah L Pett, Moira Spyer, Lewis J Haddow, et al.
Clinical Medicine (London, England)
|
April 20, 2024
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study
Daniel J van Wamelen, Silvia Rota, Monika Hartmann, et al.
The Lancet. Psychiatry
|
June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
Aravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.
Scientific Reports
|
January 27, 2025
Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS-A multicentre case-control study
Rajish S K Shil, Adam Seed, Nkongho Egbe Franklyn, et al.
Eclinicalmedicine
|
August 17, 2021
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study
Laura A Benjamin, Ross W Paterson, Rachel Moll, et al.
Brain Communications
|
August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Ross W Paterson, Laura A Benjamin, Puja R Mehta, et al.
Brain Communications
|
August 19, 2021
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study
Amy L Ross Russell, Marc Hardwick, Athavan Jeyanantham, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
AIDS (London, England)
|
December 11, 2020
Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status
Sarah L Pett, Moira Spyer, Lewis J Haddow, et al.
Clinical Medicine (London, England)
|
April 20, 2024
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study
Daniel J van Wamelen, Silvia Rota, Monika Hartmann, et al.
The Lancet. Psychiatry
|
June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
Aravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.
Scientific Reports
|
January 27, 2025
Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS-A multicentre case-control study
Rajish S K Shil, Adam Seed, Nkongho Egbe Franklyn, et al.
Eclinicalmedicine
|
August 17, 2021
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study
Laura A Benjamin, Ross W Paterson, Rachel Moll, et al.
Brain Communications
|
August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes
Ross W Paterson, Laura A Benjamin, Puja R Mehta, et al.
Brain Communications
|
August 19, 2021
Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study
Amy L Ross Russell, Marc Hardwick, Athavan Jeyanantham, et al.
Page
of 4